CollPlant Biotechnologies Ltd. Announces Commercial Launch of BioInk Platform with Collink.3D? for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs
November 15, 2021 at 05:30 pm IST
CollPlant Biotechnologies announced the launch of Collink.3D, a recombinant human collagen (rhCollagen)- based BioInk solution for use in 3D bioprinting. Collink.3D, CollPlant's first commercially available rhCollagen-based BioInk product is designed to allow the scalable and reproduceable biofabrication of scaffolds, tissues and organ transplants. Made entirely from human-derived collagen, Collink.3D enables the production of scaffolds that accurately mimic the physical properties of human tissues and organs, with improved bio-functionality, safety and reproducibility.